Home » EPIC Archives: AVCT

AVCT News Archives

Antibody Mimetics

Avacta Group Plc

“The sad fact is that around 70% of cancer patients with solid based tumors don’t respond to classical chemotherapy,” said Joseph Tabernero, MD, PhD, head of Val d’Hebron Institute of ...

Read Article »

What is immunotherapy?

Avacta Group Plc

Immunotherapy is a standard treatment for some types of cancer, for example melanoma that has spread. And it is in trials for other types of cancer. What is it? Immunotherapy uses ...

Read Article »

Can Immunotherapy Improve Survival in NSCLC?

Avacta Group Plc

Patients with advanced non–small-cell lung cancer (NSCLC) who received immunotherapy, in particular immune checkpoint inhibitors in the first-line setting, lived longer than those who received chemotherapy, according to the findings ...

Read Article »

Understanding Targeted Therapy

Avacta Group Plc

Targeted therapy is a cancer treatment that uses drugs. But it is different from traditional chemotherapy, which also uses drugs to treat cancer. Targeted therapy works by targeting the cancer’s ...

Read Article »